Companies are evolving from static reports to living models by strengthening their data backbone with advanced analytics and ...
Regulating manufacturing processes in the medical device industry is challenging. But process signature verification can help manufacturers get a handle on problems before they get out of control.
A year’s worth of FDA warning letters suggest that API and finished drug manufacturers should strengthen their approach to continued process verification. A year’s worth of FDA warning letters suggest ...
Regulatory officials and industry scientists participated in a CMC Strategy Forum sponsored by CASSS in July 2015. To ensure that biotech manufacturing processes can consistently deliver high quality ...
Among the agreed-upon updates to the EPR program plan are a benchmarking process for third-party certifications and PRO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results